Seeking solutions to old problems in elderly patients with lymphoma

0
0 / 5 (0 votos)

The Lancet Haematology

Fecha de publicación: June 2018

DOI: https://doi.org/10.1016/S2352-3026(18)30065-6

Autores: Andrés José María Ferreri

Background: Diffuse large B-cell lymphoma is diagnosed in elderly patients with increasing frequency, with 40% of diagnoses now made in patients older than 70 years. Combination therapy based on anthracycline and rituximab (ie, rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP]) is the standard treatment regimen for diffuse large B-cell lymphoma. 

SEGUIR LEYENDO